As of 09-Oct-2026
2QCY26 · PKR amounts, EPS/DPS per share · YoY
Keep the current chart as the default, or switch to TradingView for advanced tools.
Prices adjusted for bonuses & splits
Revenue
Rs 10.1B
6MCY26: Rs 19.7B (-9.1%)
Net profit
Rs 1.7B
6MCY26: Rs 3.2B (+7.7%)
EPS
Rs 14.32
6MCY26: Rs 27.35 (+7.8%)
DPS
Rs 10.00
6MCY26: Rs 10.00 (+0.0%)
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
TapHover over a metric to see its trend
Choose a section to view its metrics and trend.
Closely held shares
101.32M (86.56%)
Free Float shares
15.73M (13.44%)
Market Cap
80.23B
#3 of 14 in Pharmaceuticals Companies
More announcements are available in the full announcements tab.
Fundamental metrics to determine fair value of the stock
P/E History
Companies ranked closest to HALEON by market capitalisation among the 14 companies in the Pharmaceuticals sector.
| SymbolCompany | Price (PKR) | Market cap | P/E | Dividend yield |
|---|---|---|---|---|
| GLAXO GlaxoSmithKline Pakistan | 316.6 | Rs 99.6B | 9.6x | 6.1% |
| ABOT Abbott Laboratories (Pakistan | 926.5 | Rs 90.5B | 10.5x | 4.3% |
| HALEON Haleon Pakistan (this stock) | 685.4 | Rs 78.9B | 12.1x | 4.5% |
| HINOON Highnoon Laboratories | 929.1 | Rs 49.2B | 11.8x | 5.4% |
| SEARL The Searle Company | 77.86 | Rs 45.6B | 104.4x | - |
| AGP AGP | 155.48 | Rs 43.8B | 11.9x | 5.1% |
| HPL Hoechst Pakistan | 3,961.82 | Rs 38.1B | 10.1x | 6.8% |
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products. Haleon Pakistan Limited (HALEON) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
Haleon Pakistan Limited (formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited) was incorporated in Pakistan as a public listed company under the provisions of the repealed Companies Ordinance, 1984 (now Companies Act, 2017) on 31 March 2015. The Company is a subsidiary of ‘Haleon Netherlands B.V’. The ultimate parent of the Company is Haleon plc. The Company is inter alia principally engaged in the manufacturing, marketing and sale of consumer healthcare and over the counter health products.
Haleon Pakistan Limited (HALEON) is listed on the Pakistan Stock Exchange in the Pharmaceuticals sector. It is a constituent of the KSE-100 index. It is marked Shariah-compliant on the KMI screening.
Market data on FinHisaab is delayed and dates are shown where a figure is time-sensitive. This page is for information only and is not investment advice.
Use FinHisaab's screener and focused landing pages to compare HALEON with dividend stocks, undervalued ideas, and KSE-100 companies across the Pakistan Stock Exchange.
